The Chicago Entrepreneur

: FTC orders Illumina to divest cancer test maker Grail on competition grounds

Illumina acquired Grail in 2021 despite concerns from regulators in the U.S. and Europe. The company will appeal the FTC decision.

Previous post : Virgin Orbit stock slumps after filing for Chapter 11 bankruptcy protection
Next post 3 German computer scientists bringing scalability to Bitcoin using zk-proofs